Urinary mycoestrogens and gestational weight gain in the UPSIDE pregnancy cohort
- PMID: 39567992
- PMCID: PMC11580541
- DOI: 10.1186/s12940-024-01141-8
Urinary mycoestrogens and gestational weight gain in the UPSIDE pregnancy cohort
Abstract
Background: Zearalenone (ZEN), a secondary metabolite of Fusarium fungi, is one of the most common mycotoxins in global food supplies such as cereal grains and processed food. ZEN and its metabolites are commonly referred to as mycoestrogens, due to their ability to directly bind nuclear estrogen receptors α (ER-α) and β (ER-β). Zeranol, a synthetic mycoestrogen, is administered to U.S. cattle as a growth promoter. Despite widespread human exposure and ample evidence of adverse reproductive impacts in vitro and in vivo, there has been little epidemiological research on the health impacts of ZEN exposure during pregnancy. The objective of our study was to examine associations between ZEN and gestational weight gain (GWG).
Methods: Urine samples were collected in each trimester from pregnant participants in the UPSIDE cohort (n = 286, Rochester, NY, USA). High performance liquid chromatography and high-resolution tandem mass spectrometry were used to quantify concentrations of ZEN as well as ∑mycoestrogens (composite sum of ZEN metabolites; ng/ml). Maternal weights at clinical visits were abstracted from medical records. We fitted longitudinal models of specific-gravity adjusted, log-transformed ZEN and ∑mycoestrogens in relation to total GWG (kilograms) and GWG rate (kilograms/week). We additionally examined risk of excessive GWG (in relation to Institute of Medicine guidelines) and considered effect modification by fetal sex.
Results: ZEN and ∑mycoestrogens were detected in > 93% and > 95% of samples, respectively. Mycoestrogen concentrations were positively associated with total GWG (ZEN β:0.50 kg; 95%CI: 0.13, 0.87) and GWG rate (ZEN β:0.20 kg/week; 95%CI: 0.01, 0.03). Associations tended to be stronger among participants carrying male (versus female) fetuses and results were robust to adjustment for diet.
Conclusions: Mycoestrogen exposure during pregnancy may contribute to greater GWG. Future research is needed to understand potential influences on downstream maternal and offspring health.
Keywords: Endocrine disrupting chemicals; Gestational weight gain; Mycoestrogens; Pregnancy; Zearalenone.
© 2024. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: This manuscript utilizes data collected from the ongoing prospective Understanding Pregnancy Signals in Development (UPSIDE) birth cohort. Institutional Review Boards (IRB) at the University of Rochester (IRB approval #: 58456, approval date: August 27, 2015) and Rutgers University (IRB approval #: Pro20160001514; January 27, 2017) approved all study activities. Participatns consent was obtained prior to participation in study activities. Consent for publication: Not applicable. Competing interests: OW is currently an employee of Exponent, Inc., which provides scientific consulting to the food and beverage industry and reports no conflict of interest. At the time of the data collection and analyses, OW was a student at University of Rochester. Other authors declare no conflicting interests.
Figures



Similar articles
-
Associations between mycoestrogen exposure and sex steroid hormone concentrations in maternal serum and cord blood in the UPSIDE pregnancy cohort.Int J Hyg Environ Health. 2024 Jul;260:114405. doi: 10.1016/j.ijheh.2024.114405. Epub 2024 Jun 14. Int J Hyg Environ Health. 2024. PMID: 38878407 Free PMC article.
-
Sociodemographic and dietary predictors of maternal and placental mycoestrogen concentrations in a US pregnancy cohort.J Expo Sci Environ Epidemiol. 2025 May;35(3):382-392. doi: 10.1038/s41370-024-00722-6. Epub 2024 Oct 4. J Expo Sci Environ Epidemiol. 2025. PMID: 39363096 Free PMC article.
-
Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes.Cochrane Database Syst Rev. 2018 Jul 24;7(7):CD010564. doi: 10.1002/14651858.CD010564.pub2. Cochrane Database Syst Rev. 2018. PMID: 30039871 Free PMC article.
-
The positive effect of malaria IPTp-SP on birthweight is mediated by gestational weight gain but modifiable by maternal carriage of enteric pathogens.EBioMedicine. 2022 Mar;77:103871. doi: 10.1016/j.ebiom.2022.103871. Epub 2022 Feb 23. EBioMedicine. 2022. PMID: 35217408 Free PMC article. Clinical Trial.
-
Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes.Cochrane Database Syst Rev. 2016 Jun 7;2016(6):CD005542. doi: 10.1002/14651858.CD005542.pub3. Cochrane Database Syst Rev. 2016. PMID: 27272351 Free PMC article.
References
-
- Mousavi Khaneghah A, Fakhri Y, Raeisi S, Armoon B, Sant’Ana AS. Prevalence and concentration of ochratoxin A, zearalenone, deoxynivalenol and total aflatoxin in cereal-based products: a systematic review and meta-analysis. Food Chem Toxicol. 2018;118:830–48. - PubMed
-
- Rai A, Das M, Tripathi A. Occurrence and toxicity of a fusarium mycotoxin, zearalenone. Crit Rev Food Sci Nutr. 2020;60(16):2710–29. - PubMed
-
- Mycotoxin fact sheet (Updated May 9, 2018). https://www.who.int/news-room/fact-sheets/detail/mycotoxins. Accessed 24 Jan 2021.
-
- Ralgro. https://www.merck-animal-health-usa.com/species/cattle/products/ralgro. Accessed 9 May 2024.
-
- Kowalska K, Habrowska-Górczyńska DE, Piastowska-Ciesielska AW. Zearalenone as an endocrine disruptor in humans. Environ Toxicol Pharmacol. 2016;48:141–9. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources